HALO key data
Halozyme Therapeutics (Nasdaq: HALO) has a market capitalization of $13.90B. Last close $122.50 (as of 2026-10-20); 52-week range $61.23 to $123.60.
Halozyme Therapeutics (Nasdaq: HALO) has a market capitalization of $13.90B. Last close $122.50 (as of 2026-10-20); 52-week range $61.23 to $123.60.